Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of British Columbia

$17,500.00

Investigating the Metabolic Relationships Between Soluble CD13, Glutamic Acid and Alpha Ketoglutaric Acid in Chronic Graft Versus Host Disease

FY 2021-22

Summary
When Transplant Therapy Goes Awry: Investigating the Molecular Changes in Graft Versus Host DiseaseStem cell transplantation is a lifesaving treatment for people with advanced blood cancers. However, a serious complication of this therapy is chronic graft versus host disease, where immune cells from the donor attack the tissues of the recipient. Twenty-five percent of pediatric patients and 60% of adult patients develop chronic graft versus host disease, which is associated with permanent organ damage and a 10-25% mortality rate. Although the disease is common, the molecular changes that occur in patients organs are poorly understood. Previously, our research group developed a database of biological markers from blood samples of children with chronic graft versus host disease. Based on these markers, we are now generating diagnostic software to predict the risk of developing chronic graft versus host disease after transplant. In addition, this previous work found specific markers that may be related to disease severity, but how they cause ongoing damage is unknown. This project will investigate: (1) adult chronic graft versus host disease samples to validate our list of biological markers found in children and (2) the specific function of the markers linked to disease progression to identify potential drug targets for treatment. This project is important because chronic graft versus host disease frequently complicates a stem cell transplant, often with severe long-term consequences including death. Completion of my work will result in the development of a diagnostic tool to predict the occurrence of graft versus host disease, and the potential identification of new drug targets to improve treatment outcomes and quality of life for patients.
Program
Master's Award: Canada Graduate Scholarships
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
466710
Name
Johnston Liam
Region
British Columbia
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Investigating the Metabolic Relationships Between Soluble CD13, Glutamic Acid and Alpha Ketoglutaric Acid in Chronic Graft Versus Host Disease
Programtype2
Studentship Programs
Orgnameinp2
University of British Columbia
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Adult; Alpha Ketoglutaric Acid; Bone Marrow Transplant; Children; Chronic Graft Versus Host Disease; Glutamic Acid; Immune Profile; Metabolomics; Oncology; Soluble Cd13
Abstract
When Transplant Therapy Goes Awry: Investigating the Molecular Changes in Graft Versus Host DiseaseStem cell transplantation is a lifesaving treatment for people with advanced blood cancers. However, a serious complication of this therapy is chronic graft versus host disease, where immune cells from the donor attack the tissues of the recipient. Twenty-five percent of pediatric patients and 60% of adult patients develop chronic graft versus host disease, which is associated with permanent organ damage and a 10-25% mortality rate. Although the disease is common, the molecular changes that occur in patients organs are poorly understood. Previously, our research group developed a database of biological markers from blood samples of children with chronic graft versus host disease. Based on these markers, we are now generating diagnostic software to predict the risk of developing chronic graft versus host disease after transplant. In addition, this previous work found specific markers that may be related to disease severity, but how they cause ongoing damage is unknown. This project will investigate: (1) adult chronic graft versus host disease samples to validate our list of biological markers found in children and (2) the specific function of the markers linked to disease progression to identify potential drug targets for treatment. This project is important because chronic graft versus host disease frequently complicates a stem cell transplant, often with severe long-term consequences including death. Completion of my work will result in the development of a diagnostic tool to predict the occurrence of graft versus host disease, and the potential identification of new drug targets to improve treatment outcomes and quality of life for patients.
Competitiondate
202112
Approvedterm2
1 yr 0 mth
Pinamesdelim
Johnston, Liam
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~